Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors

NCT04165330 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor, Adult
Soft Tissue Sarcoma
Non Small Cell Lung Cancer
Small Cell Lung Cancer

Interventions

DRUG: AL3818
DRUG: Nivolumab Injection

Sponsor

Sarcoma Oncology Research Center, LLC

Collaborators

[object Object]